Immunosuppressives Unlikely to Raise Cancer Risk in IBD Patients With Prior Cancer

Inflammatory Bowel Disease News

Immunosuppressives Unlikely to Raise Cancer Risk in IBD Patients With Prior Cancer
IBD - Inflammatory Bowel DiseaseIBDCancer
  • 📰 Medscape
  • ⏱ Reading Time:
  • 44 sec. here
  • 21 min. at publisher
  • 📊 Quality Score:
  • News: 87%
  • Publisher: 55%

The findings add to a growing body of literature supporting the relative safety of immunosuppressive therapy to treat IBD in patients who have a history of cancer.

In patients with inflammatory bowel disease and a history of cancer, immunosuppressive therapies don't appear to increase the risk for incident cancer, according to an interim analysis of the SAPPHIRE registry.

In the interim analysis, Itzkowitz and colleagues looked at the development of incident cancer . The researchers excluded patients receiving active cancer treatment or who had more than one cancer before enrollment. Index cancers were solid organ , dermatologic , gastrointestinal , and hematologic . Of index cancers with known stage information, 33% were stage I.

In an unadjusted analysis, the crude rate of incident cancer in unexposed patients was 2.58 per 100 person-years vs 4.78 per 100 person-years among patients exposed to immunosuppression . SAPPHIRE researchers plan to continue to follow the existing patients and enroll new patients, particularly as new IBD medications are introduced into clinical practice, Itzkowitz said. The research team is also considering studies that investigate patients with IBD who are undergoing active cancer treatment.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

IBD - Inflammatory Bowel Disease IBD Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Cancer Risk Biologic Therapy Biologics Nonmelanoma Skin Cancer Skin Cancer Malignant Skin Neoplasm Colorectal Cancer Colorectal Cancer (CRC) Immunosuppressive Therapy Immunosuppressive Agents Immunosuppressive Drugs Immunocompromise Immunocompromised

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Majority Of Consumers Unlikely Or Very Unlikely To Buy An EVMajority Of Consumers Unlikely Or Very Unlikely To Buy An EVSupport for EVs is falling, while the number of people saying no is climbing
Read more »

HPV Vaccine Offers Cancer Protection Beyond Cervical CancerHPV Vaccine Offers Cancer Protection Beyond Cervical CancerHPV vaccination protects not only against cervical cancer in women but also other HPV-related cancers in men and women, most notably head and neck cancer in men, new data showed.
Read more »

Eat Plants, Beat Cancer: New Study Links Vegetables To Lower Prostate Cancer RisksEat Plants, Beat Cancer: New Study Links Vegetables To Lower Prostate Cancer RisksScience, Space and Technology News 2024
Read more »

Underrepresentation in clinical trials leads to cancer disparities, says Fox Chase Cancer Center’s Camille RaginUnderrepresentation in clinical trials leads to cancer disparities, says Fox Chase Cancer Center’s Camille RaginWant to reduce racial disparities in cancer? Make clinical trials more diverse, a Fox Chase researcher says.
Read more »

Françoise Hardy, renowned French singer-songwriter, has died at 80Françoise Hardy, renowned French singer-songwriter, has died at 80Hardy was diagnosed with lymphatic cancer in 2004, and also had laryngeal cancer.
Read more »

Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare caseImmunotherapy to treat cancer gave rise to 2nd cancer in extremely rare caseMiriam Bergeret is a science writer and editor based in Toronto, Canada. Miriam holds a master's degree in laboratory medicine and pathobiology from the University of Toronto, where she also studied science journalism and communication.
Read more »



Render Time: 2025-02-15 02:27:30